“…Over the past decades, many methods have been reported for the selective detection of antibody levels. − In addition to liquid chromatography–mass spectrometry (LC–MS)-based methods that do not require the use of an affinity ligand, a variety of methods utilizing antibodies, peptide mimotopes, and aptamers, , as the affinity ligands have been reported, such as the surface plasmon resonance (SPR), chemiluminescent, photoelectrochemical (PEC), bioluminescent, fluorescent, , quartz crystal microbalance (QCM), and electrochemical methods. − Among these methods, the electrochemical aptamer-based (E-AB) detection of antibody pharmaceuticals has received increasing attention, largely due to the good portability, low sample consumption and detection cost, and uncomplicated instrumentation. , On the basis of the binding-induced conformational change of the ferrocene (Fc)-modified DNA aptamer, for example, Nagata et al reported an E-AB method for the one-step detection of bevacizumab, with a detection limit of 9.1 nM . This method is easy to operate, low-cost, and highly selective; however, the “signal-off” detection can result in false-positive responses while the detection sensitivity remains to be further improved.…”